Core Viewpoint - Xylem Inc. reported strong financial performance for the fiscal year 2024, with total revenue reaching $8.6 billion, representing a 16% year-over-year growth, driven by robust market demand and operational efficiency [1][2][6]. Financial Performance Summary - In Q4 2024, Xylem achieved total revenue of $2.3 billion, with a net income of $326 million, resulting in an earnings per share (EPS) of $1.34, which is a 22% increase [2][4]. - The adjusted net income for Q4 2024 was $287 million, with an adjusted EPS of $1.18, reflecting a 19% growth [4]. - For the entire year of 2024, the net income was $890 million, with an EPS of $3.65, marking a 31% increase year-over-year [3][6]. Cost and Profitability Insights - The adjusted EBITDA margin for Q4 2024 was 21.0%, an increase of 140 basis points compared to the previous year, attributed to productivity improvements and effective pricing strategies [5]. - The company experienced a net profit margin increase of 190 basis points to 14.5% in Q4 2024, despite facing challenges from restructuring costs and previous year’s tax benefits [4]. Dividend Announcement - The board of directors announced a quarterly dividend of $0.40 per share for Q1 2025, representing an 11% increase from the previous dividend [5]. 2025 Financial Outlook - Xylem projects total revenue for fiscal year 2025 to be between $8.6 billion and $8.7 billion, indicating a growth of 0% to 2% based on reported figures, and 3% to 4% on an organic basis [7]. - The adjusted EBITDA margin for 2025 is expected to improve to between 21.3% and 21.8%, reflecting an increase of 70 to 120 basis points compared to 2024 [7]. - The company anticipates a free cash flow margin of 9% to 10% for the year [7].
2024年赛莱默xylem全年营收86亿美元,2025年预计继续增长